Fourth Quarter 2025 February 10, 2026 Earnings Conference Call J. David Joyner Chair and Chief Executive Officer Brian O. Newman Executive Vice President and Chief Financial Officer 1 ©2026 CVS Health and/or one of its affiliates. Confidential and proprietary. Cautionary Statement concerning forward-looking statements This presentation includes forward-looking statements. The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by or on behalf of CVS He ...

VANCOUVER, BC – TheNewswire - FEBRUARY 9th, 2026 – AMERICAN SALARS LITHIUM INC. ("AMERICAN SALARS" OR THE "COMPANY") (CSE: USLI, OTC: USLIF, FWB: Z3P, WKN: A3E2NY) is pleased to announce that its previously announced non-brokered private placement of up to CAD $175,000 at $0.105 per unit consisting of up to 1,666,666 units is now fully subscribed. Each unit is comprised of one common share and one common share purchase warrant. Each warrant entitles the holder to purchase one additional common share for a ...

CVS Health earnings came in ahead of analyst forecasts but the company is concerned about Medicare rates. ...

Core Insights - The healthcare giant experienced an 8% increase in revenue during the fourth quarter [1] Financial Performance - Revenue growth of 8% in the fourth quarter indicates strong performance [1]

Core Viewpoint - CVS Health reported earnings that exceeded analysts' expectations and maintained its profit guidance for 2026, which may alleviate concerns among investors regarding ongoing instability in the health-insurance sector [1] Summary by Relevant Categories Earnings Performance - CVS Health's earnings surpassed analysts' forecasts, indicating strong financial performance [1] Profit Guidance - The company has kept its profit guidance for 2026 unchanged, suggesting confidence in its future financial outlook [1] Market Reaction - The positive earnings report may help to calm investors who are anxious due to the persistent turmoil in the health-insurance industry [1]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to_________ Commission file number: 001-01011 CVS HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 05-0494040 (State or ...

Core Insights - CVS Health reported a decline in fourth-quarter profit but exceeded Wall Street estimates, driven by strength in its pharmacy benefit unit and robust prescription volume at its retail pharmacies [1] Financial Performance - The company experienced a decrease in profit for the fourth quarter, yet managed to outperform analysts' expectations [1] - The performance was bolstered by the pharmacy benefit unit, indicating a strong demand for prescription services [1] Business Segments - The pharmacy benefit unit showed significant strength, contributing positively to the overall performance of CVS Health [1] - Retail pharmacies also reported strong prescription volume, which played a crucial role in the company's ability to beat estimates [1]

Fourth Quarter Highlights Full-Year Highlights Operational Highlights 2026 Full-Year Guidance Exhibit 99.1 CVS HEALTH CORPORATION REPORTS FOURTH QUARTER AND FULL-YEAR 2025 RESULTS - David Joyner, CVS Health President and CEO WOONSOCKET, RHODE ISLAND, February 10, 2026 - CVS Health Corporation (NYSE: CVS) today announced operating results for the three months and year ended December 31, 2025. Financial Results Summary | | | Three | Months | | Ended | | | --- | --- | --- | --- | --- | --- | --- | | | | | Dece ...

CVS Health on Tuesday reported fourth-quarter earnings and revenue that beat estimates and reaffirmed the 2026 profit guidance that impressed investors, signaling steady progress in the health-care giant's turnaround plan. "'24 was a tough year for the company. So '25 righted the ship," CVS CFO Brian Newman said in an interview. CVS, which operates one of the largest pharmacy chains in the U.S., sees full-year profit coming in between $7 to $7.20 per share. That's in line with the $7.17 per share that analy ...

Group 1 - The article provides a market analysis focusing on the S&P 500, State Street® Consumer Staples Select Sector SPDR® ETF, and iShares Expanded Tech-Software Sector ETF [1] - It highlights the performance trends and investment opportunities within these sectors [1] - The analysis is available on Investing.com, indicating a resource for investors seeking detailed insights [1]